The global market for Severe Asthma Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Severe Asthma Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Severe Asthma Treatment by region & country, by Type, and by Application.

The Severe Asthma Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Severe Asthma Treatment.

Market Segmentation

Scope of Severe Asthma Treatment - Market Report

Report Metric	Details
Report Name	Severe Asthma Treatment - Market
CAGR	5%
Segment by Type:	Oral lnhaled lntravenous Subcutaneous
Segment by Application	Children Adults Teenagers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma, Morphosys, Roche, Avalo Therapeutics, Suzhou Connect Biopharmaceuticals, Pieris Pharma, Biosion
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Severe Asthma Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Severe Asthma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Severe Asthma Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Severe Asthma Treatment - Market report?

Ans: The main players in the Severe Asthma Treatment - Market are Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma, Morphosys, Roche, Avalo Therapeutics, Suzhou Connect Biopharmaceuticals, Pieris Pharma, Biosion

What are the Application segmentation covered in the Severe Asthma Treatment - Market report?

Ans: The Applications covered in the Severe Asthma Treatment - Market report are Children, Adults, Teenagers

What are the Type segmentation covered in the Severe Asthma Treatment - Market report?

Ans: The Types covered in the Severe Asthma Treatment - Market report are Oral, lnhaled, lntravenous, Subcutaneous

1 Market Overview

1.1 Severe Asthma Treatment Product Introduction

1.2 Global Severe Asthma Treatment Market Size Forecast

1.2.1 Global Severe Asthma Treatment Sales Value (2019-2030)

1.2.2 Global Severe Asthma Treatment Sales Volume (2019-2030)

1.2.3 Global Severe Asthma Treatment Sales Price (2019-2030)

1.3 Severe Asthma Treatment Market Trends & Drivers

1.3.1 Severe Asthma Treatment Industry Trends

1.3.2 Severe Asthma Treatment Market Drivers & Opportunity

1.3.3 Severe Asthma Treatment Market Challenges

1.3.4 Severe Asthma Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Severe Asthma Treatment Players Revenue Ranking (2023)

2.2 Global Severe Asthma Treatment Revenue by Company (2019-2024)

2.3 Global Severe Asthma Treatment Players Sales Volume Ranking (2023)

2.4 Global Severe Asthma Treatment Sales Volume by Company Players (2019-2024)

2.5 Global Severe Asthma Treatment Average Price by Company (2019-2024)

2.6 Key Manufacturers Severe Asthma Treatment Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Severe Asthma Treatment Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Severe Asthma Treatment

2.9 Severe Asthma Treatment Market Competitive Analysis

2.9.1 Severe Asthma Treatment Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Severe Asthma Treatment Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Severe Asthma Treatment as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral

3.1.2 lnhaled

3.1.3 lntravenous

3.1.4 Subcutaneous

3.2 Global Severe Asthma Treatment Sales Value by Type

3.2.1 Global Severe Asthma Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Severe Asthma Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Severe Asthma Treatment Sales Value, by Type (%) (2019-2030)

3.3 Global Severe Asthma Treatment Sales Volume by Type

3.3.1 Global Severe Asthma Treatment Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Severe Asthma Treatment Sales Volume, by Type (2019-2030)

3.3.3 Global Severe Asthma Treatment Sales Volume, by Type (%) (2019-2030)

3.4 Global Severe Asthma Treatment Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Children

4.1.2 Adults

4.1.3 Teenagers

4.2 Global Severe Asthma Treatment Sales Value by Application

4.2.1 Global Severe Asthma Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Severe Asthma Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Severe Asthma Treatment Sales Value, by Application (%) (2019-2030)

4.3 Global Severe Asthma Treatment Sales Volume by Application

4.3.1 Global Severe Asthma Treatment Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Severe Asthma Treatment Sales Volume, by Application (2019-2030)

4.3.3 Global Severe Asthma Treatment Sales Volume, by Application (%) (2019-2030)

4.4 Global Severe Asthma Treatment Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Severe Asthma Treatment Sales Value by Region

5.1.1 Global Severe Asthma Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Severe Asthma Treatment Sales Value by Region (2019-2024)

5.1.3 Global Severe Asthma Treatment Sales Value by Region (2025-2030)

5.1.4 Global Severe Asthma Treatment Sales Value by Region (%), (2019-2030)

5.2 Global Severe Asthma Treatment Sales Volume by Region

5.2.1 Global Severe Asthma Treatment Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Severe Asthma Treatment Sales Volume by Region (2019-2024)

5.2.3 Global Severe Asthma Treatment Sales Volume by Region (2025-2030)

5.2.4 Global Severe Asthma Treatment Sales Volume by Region (%), (2019-2030)

5.3 Global Severe Asthma Treatment Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Severe Asthma Treatment Sales Value, 2019-2030

5.4.2 North America Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Severe Asthma Treatment Sales Value, 2019-2030

5.5.2 Europe Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Severe Asthma Treatment Sales Value, 2019-2030

5.6.2 Asia Pacific Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Severe Asthma Treatment Sales Value, 2019-2030

5.7.2 South America Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Severe Asthma Treatment Sales Value, 2019-2030

5.8.2 Middle East & Africa Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Severe Asthma Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Severe Asthma Treatment Sales Value

6.2.1 Key Countries/Regions Severe Asthma Treatment Sales Value, 2019-2030

6.2.2 Key Countries/Regions Severe Asthma Treatment Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Severe Asthma Treatment Sales Value, 2019-2030

6.3.2 United States Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Severe Asthma Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Severe Asthma Treatment Sales Value, 2019-2030

6.4.2 Europe Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Severe Asthma Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Severe Asthma Treatment Sales Value, 2019-2030

6.5.2 China Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Severe Asthma Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Severe Asthma Treatment Sales Value, 2019-2030

6.6.2 Japan Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Severe Asthma Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Severe Asthma Treatment Sales Value, 2019-2030

6.7.2 South Korea Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Severe Asthma Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Severe Asthma Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Severe Asthma Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Severe Asthma Treatment Sales Value, 2019-2030

6.9.2 India Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Severe Asthma Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Teva Pharmaceutical

7.1.1 Teva Pharmaceutical Company Information

7.1.2 Teva Pharmaceutical Introduction and Business Overview

7.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Teva Pharmaceutical Severe Asthma Treatment Product Offerings

7.1.5 Teva Pharmaceutical Recent Development

7.2 AstraZeneca

7.2.1 AstraZeneca Company Information

7.2.2 AstraZeneca Introduction and Business Overview

7.2.3 AstraZeneca Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.2.4 AstraZeneca Severe Asthma Treatment Product Offerings

7.2.5 AstraZeneca Recent Development

7.3 GlaxoSmithKline

7.3.1 GlaxoSmithKline Company Information

7.3.2 GlaxoSmithKline Introduction and Business Overview

7.3.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GlaxoSmithKline Severe Asthma Treatment Product Offerings

7.3.5 GlaxoSmithKline Recent Development

7.4 Novartis

7.4.1 Novartis Company Information

7.4.2 Novartis Introduction and Business Overview

7.4.3 Novartis Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Novartis Severe Asthma Treatment Product Offerings

7.4.5 Novartis Recent Development

7.5 Sanofi

7.5.1 Sanofi Company Information

7.5.2 Sanofi Introduction and Business Overview

7.5.3 Sanofi Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Sanofi Severe Asthma Treatment Product Offerings

7.5.5 Sanofi Recent Development

7.6 Regeneron Pharmaceutical

7.6.1 Regeneron Pharmaceutical Company Information

7.6.2 Regeneron Pharmaceutical Introduction and Business Overview

7.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Regeneron Pharmaceutical Severe Asthma Treatment Product Offerings

7.6.5 Regeneron Pharmaceutical Recent Development

7.7 4D Pharma plc

7.7.1 4D Pharma plc Company Information

7.7.2 4D Pharma plc Introduction and Business Overview

7.7.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.7.4 4D Pharma plc Severe Asthma Treatment Product Offerings

7.7.5 4D Pharma plc Recent Development

7.8 AB Pharma

7.8.1 AB Pharma Company Information

7.8.2 AB Pharma Introduction and Business Overview

7.8.3 AB Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.8.4 AB Pharma Severe Asthma Treatment Product Offerings

7.8.5 AB Pharma Recent Development

7.9 Morphosys

7.9.1 Morphosys Company Information

7.9.2 Morphosys Introduction and Business Overview

7.9.3 Morphosys Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Morphosys Severe Asthma Treatment Product Offerings

7.9.5 Morphosys Recent Development

7.10 Roche

7.10.1 Roche Company Information

7.10.2 Roche Introduction and Business Overview

7.10.3 Roche Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Roche Severe Asthma Treatment Product Offerings

7.10.5 Roche Recent Development

7.11 Avalo Therapeutics

7.11.1 Avalo Therapeutics Company Information

7.11.2 Avalo Therapeutics Introduction and Business Overview

7.11.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Avalo Therapeutics Severe Asthma Treatment Product Offerings

7.11.5 Avalo Therapeutics Recent Development

7.12 Suzhou Connect Biopharmaceuticals

7.12.1 Suzhou Connect Biopharmaceuticals Company Information

7.12.2 Suzhou Connect Biopharmaceuticals Introduction and Business Overview

7.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Offerings

7.12.5 Suzhou Connect Biopharmaceuticals Recent Development

7.13 Pieris Pharma

7.13.1 Pieris Pharma Company Information

7.13.2 Pieris Pharma Introduction and Business Overview

7.13.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Pieris Pharma Severe Asthma Treatment Product Offerings

7.13.5 Pieris Pharma Recent Development

7.14 Biosion

7.14.1 Biosion Company Information

7.14.2 Biosion Introduction and Business Overview

7.14.3 Biosion Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Biosion Severe Asthma Treatment Product Offerings

7.14.5 Biosion Recent Development

8 Industry Chain Analysis

8.1 Severe Asthma Treatment Industrial Chain

8.2 Severe Asthma Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Severe Asthma Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Severe Asthma Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical

Astrazeneca plc

Novartis

Regeneron Pharmaceutical

Suzhou Connect Biopharmaceuticals

List of Tables

Table 1. Severe Asthma Treatment Market Trends

Table 2. Severe Asthma Treatment Market Drivers & Opportunity

Table 3. Severe Asthma Treatment Market Challenges

Table 4. Severe Asthma Treatment Market Restraints

Table 5. Global Severe Asthma Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Severe Asthma Treatment Revenue Market Share by Company (2019-2024)

Table 7. Global Severe Asthma Treatment Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Severe Asthma Treatment Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Severe Asthma Treatment Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Severe Asthma Treatment Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Severe Asthma Treatment Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Severe Asthma Treatment

Table 13. Global Severe Asthma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Severe Asthma Treatment as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Severe Asthma Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Severe Asthma Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Severe Asthma Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Severe Asthma Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Severe Asthma Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Severe Asthma Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Severe Asthma Treatment Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Severe Asthma Treatment Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Severe Asthma Treatment Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Severe Asthma Treatment Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Severe Asthma Treatment Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Severe Asthma Treatment Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Severe Asthma Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Severe Asthma Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Severe Asthma Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Severe Asthma Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Severe Asthma Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Severe Asthma Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Severe Asthma Treatment Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Severe Asthma Treatment Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Severe Asthma Treatment Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Severe Asthma Treatment Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Severe Asthma Treatment Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Severe Asthma Treatment Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Severe Asthma Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Severe Asthma Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Severe Asthma Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Severe Asthma Treatment Sales Value by Region (2019-2024) & (%)

Table 44. Global Severe Asthma Treatment Sales Value by Region (2025-2030) & (%)

Table 45. Global Severe Asthma Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Severe Asthma Treatment Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Severe Asthma Treatment Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Severe Asthma Treatment Sales Volume by Region (2019-2024) & (%)

Table 49. Global Severe Asthma Treatment Sales Volume by Region (2025-2030) & (%)

Table 50. Global Severe Asthma Treatment Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Severe Asthma Treatment Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Severe Asthma Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Severe Asthma Treatment Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Severe Asthma Treatment Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Severe Asthma Treatment Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Severe Asthma Treatment Sales Volume, (2025-2030) & (K Units)

Table 57. Teva Pharmaceutical Company Information

Table 58. Teva Pharmaceutical Introduction and Business Overview

Table 59. Teva Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Teva Pharmaceutical Severe Asthma Treatment Product Offerings

Table 61. Teva Pharmaceutical Recent Development

Table 62. AstraZeneca Company Information

Table 63. AstraZeneca Introduction and Business Overview

Table 64. AstraZeneca Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. AstraZeneca Severe Asthma Treatment Product Offerings

Table 66. AstraZeneca Recent Development

Table 67. GlaxoSmithKline Company Information

Table 68. GlaxoSmithKline Introduction and Business Overview

Table 69. GlaxoSmithKline Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. GlaxoSmithKline Severe Asthma Treatment Product Offerings

Table 71. GlaxoSmithKline Recent Development

Table 72. Novartis Company Information

Table 73. Novartis Introduction and Business Overview

Table 74. Novartis Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Novartis Severe Asthma Treatment Product Offerings

Table 76. Novartis Recent Development

Table 77. Sanofi Company Information

Table 78. Sanofi Introduction and Business Overview

Table 79. Sanofi Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Sanofi Severe Asthma Treatment Product Offerings

Table 81. Sanofi Recent Development

Table 82. Regeneron Pharmaceutical Company Information

Table 83. Regeneron Pharmaceutical Introduction and Business Overview

Table 84. Regeneron Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Regeneron Pharmaceutical Severe Asthma Treatment Product Offerings

Table 86. Regeneron Pharmaceutical Recent Development

Table 87. 4D Pharma plc Company Information

Table 88. 4D Pharma plc Introduction and Business Overview

Table 89. 4D Pharma plc Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. 4D Pharma plc Severe Asthma Treatment Product Offerings

Table 91. 4D Pharma plc Recent Development

Table 92. AB Pharma Company Information

Table 93. AB Pharma Introduction and Business Overview

Table 94. AB Pharma Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. AB Pharma Severe Asthma Treatment Product Offerings

Table 96. AB Pharma Recent Development

Table 97. Morphosys Company Information

Table 98. Morphosys Introduction and Business Overview

Table 99. Morphosys Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Morphosys Severe Asthma Treatment Product Offerings

Table 101. Morphosys Recent Development

Table 102. Roche Company Information

Table 103. Roche Introduction and Business Overview

Table 104. Roche Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Roche Severe Asthma Treatment Product Offerings

Table 106. Roche Recent Development

Table 107. Avalo Therapeutics Company Information

Table 108. Avalo Therapeutics Introduction and Business Overview

Table 109. Avalo Therapeutics Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Avalo Therapeutics Severe Asthma Treatment Product Offerings

Table 111. Avalo Therapeutics Recent Development

Table 112. Suzhou Connect Biopharmaceuticals Company Information

Table 113. Suzhou Connect Biopharmaceuticals Introduction and Business Overview

Table 114. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Offerings

Table 116. Suzhou Connect Biopharmaceuticals Recent Development

Table 117. Pieris Pharma Company Information

Table 118. Pieris Pharma Introduction and Business Overview

Table 119. Pieris Pharma Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Pieris Pharma Severe Asthma Treatment Product Offerings

Table 121. Pieris Pharma Recent Development

Table 122. Biosion Company Information

Table 123. Biosion Introduction and Business Overview

Table 124. Biosion Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Biosion Severe Asthma Treatment Product Offerings

Table 126. Biosion Recent Development

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Severe Asthma Treatment Downstream Customers

Table 130. Severe Asthma Treatment Distributors List

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Severe Asthma Treatment Product Picture

Figure 2. Global Severe Asthma Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Severe Asthma Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Severe Asthma Treatment Sales Volume (2019-2030) & (K Units)

Figure 5. Global Severe Asthma Treatment Sales Price (2019-2030) & (US$/Unit)

Figure 6. Severe Asthma Treatment Report Years Considered

Figure 7. Global Severe Asthma Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Severe Asthma Treatment Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Severe Asthma Treatment Revenue in 2023

Figure 10. Severe Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Oral Picture

Figure 12. lnhaled Picture

Figure 13. lntravenous Picture

Figure 14. Subcutaneous Picture

Figure 15. Global Severe Asthma Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Severe Asthma Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Severe Asthma Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Severe Asthma Treatment Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Severe Asthma Treatment Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Children

Figure 21. Product Picture of Adults

Figure 22. Product Picture of Teenagers

Figure 23. Global Severe Asthma Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Severe Asthma Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Severe Asthma Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Severe Asthma Treatment Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Severe Asthma Treatment Price by Application (2019-2030) & (US$/Unit)

Figure 28. North America Severe Asthma Treatment Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Severe Asthma Treatment Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Severe Asthma Treatment Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Severe Asthma Treatment Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Severe Asthma Treatment Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Severe Asthma Treatment Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Severe Asthma Treatment Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Severe Asthma Treatment Sales Volume (%), (2019-2030)

Figure 40. United States Severe Asthma Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Severe Asthma Treatment Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Severe Asthma Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Severe Asthma Treatment Sales Value by Application (%), 2023 VS 2030

Figure 46. China Severe Asthma Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

Figure 48. China Severe Asthma Treatment Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Severe Asthma Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Severe Asthma Treatment Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Severe Asthma Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Severe Asthma Treatment Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Severe Asthma Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Severe Asthma Treatment Sales Value by Application (%), 2023 VS 2030

Figure 58. India Severe Asthma Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Severe Asthma Treatment Sales Value by Type (%), 2023 VS 2030

Figure 60. India Severe Asthma Treatment Sales Value by Application (%), 2023 VS 2030

Figure 61. Severe Asthma Treatment Industrial Chain

Figure 62. Severe Asthma Treatment Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions